APPOINTMENTS: Cancer Research UK, LEUKOCARE, Astellas, Decibel Therapeutics, Bicycle Therapeutics, Asterias Biotherapeutics, Novo A/S.
Announcements include Peter Chambré’s appointment as Cancer Research UK’s trustee, Sandoz’s former CEO’s appointment to LEUKOCARE’s board of directors and Joseph Devaney being appointed Astellas’ vice president, government affairs and policy.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.